Associated Papers
A prospective, multicenter, comprehensive genomic profile signature study in patients with EGFR-mutant advanced non-small cell lung cancer at the first-line treatment failure of osimertinib.
Shi Y et al.
Signal Transduction and Targeted Therapy, 2025
41326340 (PubMed )
Supplement: 41392_2025_2481_MOESM1_ESM.docx
Expression and alternative splicing of the cyclin-dependent kinase inhibitor-3 gene in human cancer.
Cress WD et al.
The International Journal of Biochemistry & Cell Biology, 2017
Select a paper to view details